Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic implementation projects 2022
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

Australian researchers reveal genetic links underlying neuroendocrine pancreatic cancer

Home All news & events News Australian researchers reveal genetic links…

The researchers carried out whole genome sequencing of tumours from 100 Australian patients recruited through the Australian Pancreatic Cancer Genome Initiative (APGI), and found that as many as one-in-five patients with pancreatic neuroendocrine tumours (PanNETs) had a clear genetic predisposition for their cancers, even though they had no family history of the disease.

The breakthrough is the work of researchers based at the University of Melbourne, the Garvan Institute of Medical Research, QIMR Berghofer Medical Research Institute, The University of Queensland and the Children’s Medical Research Institute, as well as European and US teams, that undertook to create an ‘atlas’ of the mutations responsible for causing each and every major type of pancreatic cancer.

These findings bring hope of identifying those at risk of these cancers, and opportunities for targeted treatment of these diseases.

Source: See the full original article published on HealthCanal.

View the profile of the study co-leader, and Australian Genomics Steering Committee member, Professor Sean Grimmond (The University of Melbourne).